Connection
Thomas Attard to Pharmacogenetics
This is a "connection" page, showing publications Thomas Attard has written about Pharmacogenetics.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.189 |
|
|
|
-
Chevalier R, Attard T, Van Driest SL, Shakhnovich V. A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens. Expert Opin Drug Metab Toxicol. 2023 02; 19(2):53-56.
Score: 0.189